Document ID: chunk:federal_register_of_legislation:F2024L01730:schedule:1:p11
Version: federal_register_of_legislation:F2024L01730
Segment Type: schedule
Provision Reference: sch 1 (pt 11/30)
Character Range: 32653–35484

in numerical order in the column headed "Purposes": P16238 P16249
[61] Schedule 1, Part 1, entry for Imatinib in the form Capsule 400 mg (as mesilate) [Brand: Imatinib GH; Maximum Quantity: 30; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[62] Schedule 1, Part 1, entry for Imatinib in the form Capsule 400 mg (as mesilate) [Brand: Imatinib-APOTEX; Maximum Quantity: 30; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[63] Schedule 1, Part 1, entry for Imatinib in the form Capsule 400 mg (as mesilate) [Brand: IMATINIB-DRLA; Maximum Quantity: 30; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[64] Schedule 1, Part 1, entry for Imatinib in the form Tablet 100 mg (as mesilate) [Brand: Gilmat; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[65] Schedule 1, Part 1, entry for Imatinib in the form Tablet 100 mg (as mesilate) [Brand: Glivec; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[66] Schedule 1, Part 1, entry for Imatinib in the form Tablet 100 mg (as mesilate) [Brand: Imanib; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert in numerical order in the column headed "Circumstances": C16238 C16249
(c) omit from the column headed "Purposes": P9203 P9207
(d) insert in numerical order in the column headed "Purposes": P16238 P16249
[67] Schedule 1, Part 1, entry for Imatinib in the form Tablet 100 mg (as mesilate) [Brand: IMATINIB RBX; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9203 C9207
(b) insert